Does hyperthermic intraoperative chemotherapy lead to improved outcomes in patients with ovarian cancer? A single center cohort study in 111 consecutive patients

Does hyperthermic intraoperative chemotherapy lead to improved outcomes in patients with ovarian cancer? A single center cohort study in 111 consecutive patients

<p>Abstract</p> <p>Background</p> <p>For recurrent disease or primary therapy of advanced ovarian cancer, cytoreductive surgery (CRS) followed by adjuvant chemotherapy is a therapeutic option. The aim of this study was to evaluate the outcome for patients with epithelia...

Full description

Bibliographic Details
Main Authors: Warschkow Rene, Tarantino Ignazio, Lange Jochen, Müller Sascha A, Schmied Bruno M, Zünd Michael, Steffen Thomas
Format: Article
Language:English
Published: BMC 2012-06-01
Series:Patient Safety in Surgery
Subjects:
Cytoreductive surgery
Peritonectomy
Hyperthermic intraperitoneal chemotherapy
Epithelial ovarian cancer
Peritoneal carcinomatosis
Online Access:http://www.pssjournal.com/content/6/1/12

Internet

http://www.pssjournal.com/content/6/1/12

Similar Items